NTRA - Natera, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$268.90
DETAILS
HIGH:
$310.00
LOW:
$220.00
MEDIAN:
$270.00
CONSENSUS:
$268.90
DOWNSIDE:
0.39%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Druckenmiller | 3,063,606 | $612.7M | 18.1% | +552,249 | INCREASED |
| Cooperman | 491,336 | $98.3M | 0.1% | -62,271 | DECREASED |
| Wood | 444,199 | $88.8M | 0.1% | +318,887 | INCREASED |
| Greenblatt | 93,132 | $18.6M | 0.1% | +11,866 | INCREASED |
| Dalio | 25,237 | $5.0M | 0.0% | +25,237 | NEW |
| Laffont | 0 | $0 | -- | -4,960 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-06 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 1,000 | $280.00 | $280K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 484 | $269.87 | $131K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 1,357 | $270.96 | $368K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 1,400 | $276.24 | $387K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 2,045 | $277.29 | $567K |
| 2026-07-01 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | SELL | 300 | $274.06 | $82K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 300 | $278.77 | $84K |
| 2026-07-01 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | SELL | 100 | $267.19 | $27K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 454 | $272.14 | $124K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 500 | $274.19 | $137K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 1,568 | $266.79 | $418K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 3,705 | $268.11 | $993K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 1,100 | $275.20 | $303K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 1,955 | $278.25 | $544K |
| 2026-07-01 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | SELL | 2,600 | $272.99 | $710K |
| 2026-07-01 | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | SELL | 1,932 | $268.99 | $520K |
| 2026-06-26 | Chapman Rowan E | director | A-Award | 1,571 | -- | -- |
| 2026-06-26 | BOTHA ROELOF | director | A-Award | 120 | -- | -- |
| 2026-06-26 | Marcus Gail Boxer | director | A-Award | 98 | -- | -- |
| 2026-06-26 | Chapman Rowan E | director | A-Award | 103 | -- | -- |
| 2026-06-26 | Bertagnolli Monica | director | A-Award | 1,571 | -- | -- |
| 2026-06-26 | Baynes Roy D. | director | A-Award | 75 | -- | -- |
| 2026-06-26 | Rubin Eric H | director | A-Award | 75 | -- | -- |
| 2026-06-26 | ROSENMAN HERM | director | A-Award | 1,571 | -- | -- |
| 2026-06-26 | Lynch Thomas J. Jr. | director | A-Award | 1,905 | -- | -- |